Currently predicting for Thu, 4 Jun 2026

ZYME Prediction Chart

ZYME Predictions History

Latest community submissions for ZYME.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 29, 2025 Bullish $19.38 V 1
AlexVel AlexVel Pro
Oct 30, 2023 $6.68 +0.44% $6.99 V 95.56% 1
Oct 27, 2023 $6.78 +1.54% $6.65 X 98.00% 0
Oct 27, 2023 $6.74 +0.96% $6.65 X 98.58% 1
AlexVel AlexVel Pro
Oct 27, 2023 $6.56 -1.80% $6.65 V 98.65% 2
AlexVel AlexVel Pro
Aug 24, 2023 $7.84 -1.63% $7.66 V 97.65% 1
AlexVel AlexVel Pro
Aug 23, 2023 $8.01 +1.91% $7.97 V 99.50% 4
Apr 14, 2023 $9.87 -1.98% $9.93 V 99.40% 4
Apr 14, 2023 $9.95 -1.24% $9.93 V 99.85% 6
Apr 14, 2023 Bullish $9.93 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ZYME with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ZYMEWORKS INC
Zymeworks
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE